Transdermal Delivery of Bioidentical Progesterone with a Steroid 5α-Reductase Inhibitor (Dutasteride): a Pilot Study
Purpose: Bioavailability of transdermal progesterone is low and variable. This may be attributed to transdermal metabolism by the 5α-reductase enzymes or the direct transport to the saliva. The objective of the current study was to evaluate the effect of enzyme inhibition on the bioavailability of t...
Saved in:
Main Authors: | sara Zargar-Shoshtari (Author), Hannaneh Wahhabaghei (Author), Abdolrasoul Mehrsai (Author), Jingyuan Wen (Author), Raid Alany (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining bioidentical hormones for menopause-related symptoms
by: Whelan AM, et al.
Published: (2011) -
Influence of monoolein on progesterone transdermal delivery
by: Wanessa de Souza Cardoso Quintão, et al.
Published: (2015) -
Bioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefs
by: Whelan AM, et al.
Published: (2012) -
Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study
by: Daniels Kelly R, et al.
Published: (2011) -
Androgenic alopecia and dutasteride in hair mesotherapy: A short review
by: Estela B Busanello, et al.
Published: (2018)